Michael J. E. Greff

Associate Medical Director at KGK Science Inc.

Michael J. E. Greff, MD is an experienced professional in the field of medical monitoring, clinical operations, and clinical trial management. With a background in molecular medicine and clinical pharmacology, Michael has held various roles such as Associate Medical Director at KGK Science Inc. and Lead Sub-Investigator at Western University. Additionally, Michael has experience in organizing events, conducting wilderness canoe trips, and working in forensic toxicology. With a strong educational background in medicine and science, Michael is a valuable asset in the healthcare and research industry.

Location

London, Canada

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


KGK Science Inc.

Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies. From clinical study design to impactful product marketing, KGK has client success down to a science. At our state-of-the-art clinical research facilities, clinical staff, researchers, and regulatory experts quickly turn requests into results. We’ve guided hundreds of companies in taking their initial product concepts on to clinically proven claims and beyond, working to differentiate ideas and offer unique pathways through complex regulatory bodies including Health Canada, FDA, and FTC. Recognized globally as thought-leaders in cannabinoid science and regulation for the natural health product industry, KGK Science is proudly the first CRO in Canada to possess a Cannabis Research License, extending our 22 years of industry experience to include cannabis and hemp-derived products. As the leading CRO in the cannabis industry, KGK is focused on expertly conducting clinical trials and providing regulatory support to help bring innovative new health products to market, continuing to further global research and unlock the true value of the cannabis industry for clients and consumers.


Industries

Headquarters

London, Canada

Employees

51-200

Links